Companies will now be in the process of assessing the impact of the industry's new agreements on their portfolio of already reimbursed medicines and even their late-stage pipelines. …
Companies assess price cut impact and look ahead to April 2023
September 13, 2021 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Daily updates on COVID-19 vaccine - 24 September 2021
September 24, 2021 - - COVID-19 -
TGA rushes out another iteration of the COVID-19 advertising authorisation
September 24, 2021 - - Latest News -
Lockdown-driven delay hardly cuts it for PHARMAC review
September 24, 2021 - - Latest News -
Repurposing treatments for COVID-19 is not so simple
September 24, 2021 - - Latest News -
Amgen mandates COVID-19 vaccine for in-field staff
September 24, 2021 - - Latest News -
Sanofi marks 30 years of humanitarian program
September 24, 2021 - - Latest News -
AstraZeneca welcomes expanded approval for Forxiga
September 24, 2021 - - Latest News